LIGHT-UP outcomes: GS200 patients lose on average 11% of body weightResults from the LIGHT-UP clinical trial for adults with overweight or obesity who have prediabetes or type 2 diabetes and were treated...
LSG and RYGB-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditure6 days ago
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity6 days ago